Advertisement

In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.

Eleni Tholouli, Katherine Sturgess, Rachel E. Dickinson, Andrew Gennery, Andrew J. Cant, Graham Jackson, Jim Lordan, Sophie Hambleton, Mary A. Slatter, Venetia Bigley and Matthew Collin

Article Information

PubMed 

Print ISSN 
Online ISSN 

Article Versions


Contributors 
  • Eleni Tholouli, 1 Manchester Royal Infirmary, United Kingdom;
  • Katherine Sturgess, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;
  • Rachel E. Dickinson, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;
  • Andrew Gennery, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;
  • Andrew J. Cant, 3 Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom;
  • Graham Jackson, 4 Northern Institute for Cancer Research, Newcastle University, United Kingdom
  • Jim Lordan, 3 Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom;
  • Sophie Hambleton, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;
  • Mary A. Slatter, 3 Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom;
  • Venetia Bigley, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;
  • Matthew Collin, 2 Institute of Cellular Medicine, Newcastle University, United Kingdom;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output